✦ LIBER ✦

Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer

✍ Scribed by Tsutomu Nishiyama

Book ID: 116698762
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 433 KB
Volume: 129
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2011.12.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy and androgen ablation for c

Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer

✍ Alan Pollack; Gunar K. Zagars; Susan Kopplin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 862 KB

UP-2.140: The Efficacy of Androgen Depri

UP-2.140: The Efficacy of Androgen Deprivation Therapy in Clinically Localized Prostate Cancer

✍ T. Kim; S. Kim; B. Sung; H. Kim; D. Kim; S. Jo; H. Rhew; J. Yoon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Androgen deprivation therapy as primary

Androgen deprivation therapy as primary treatment for clinically localized prostate cancer: data from CaPSURE

✍ J. Kawakami; J. Cowan; E.P. Elkin; D.M. Latini; J. DuChane; P.R. Carroll 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Michael Froehner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Axel Madlung; Mathew Simcock; Pirus Ghadjar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Results of a Prospective Phase 2 Trial With great interest we read the article by Brown et al, who reported the results of a phase 2 study using gemcitabine and cisplatin in patients with advanced endometrial cancer. 1 Although we recognize the reported impressive activity of this regimen, we b

Comparative risk-adjusted mortality outc

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

✍ Matthew R. Cooperberg; Andrew J. Vickers; Jeanette M. Broering; Peter R. Carroll 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 2 views